Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Crisaborole

🥰Excellent
Catalog No. T4285Cas No. 906673-24-3
Alias PF-06930164, AN-2728

Crisaborole (AN-2728) is a phosphodiesterase 4 inhibitor.

Crisaborole

Crisaborole

🥰Excellent
Purity: 99.91%
Catalog No. T4285Alias PF-06930164, AN-2728Cas No. 906673-24-3
Crisaborole (AN-2728) is a phosphodiesterase 4 inhibitor.
Pack SizePriceAvailabilityQuantity
10 mg36 €In Stock
50 mg47 €In Stock
100 mg78 €In Stock
200 mg105 €In Stock
1 mL x 10 mM (in DMSO)43 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Crisaborole"

Select Batch
Purity:99.91%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Crisaborole (AN-2728) is a phosphodiesterase 4 inhibitor.
Targets&IC50
PDE4:0.49 μM
In vitro
AN-2728 inhibits PDE isozymes PDE1A3, PDE3Cat , PDE4Cat and PDE7A1 with IC50 values of 6.1, 6.4, 0.11 and 0.73 μM. AN-2728 inhibits PDE4, TNF-α, IL-2, IFN-γ, IL-5 and IL-10 with IC50 values of 0.49, 0.54, 0.61, 0.83, 2.4 and 5.3 μM. AN-2728 shows the most potent activity against PDE4 catalytic domain, but it also shows inhibition against PDE1A3, PDE3Cat, and PDE7A1. Crystallography reveals that interaction of benzoxaboroles with the hydrophobic pocket in the PDE4 catalytic domain increase their affinity for PDE4. These benzoxaboroles strongly suppresses the secretion of cytokines associated with Ps and AD.
In vivo
AN-2728 is well tolerated and significantly impacts efficacy markers, showing comparable results to positive controls in clinical trials. It effectively inhibits ear edema induced by phorbol ester with a dosing of 1 mg/ear×2 (78% and 68%, respectively), mirroring the efficacy of dexamethasone. This suggests AN-2728 possesses notable anti-inflammatory properties and skin penetration capabilities.
AliasPF-06930164, AN-2728
Chemical Properties
Molecular Weight251.05
FormulaC14H10BNO3
Cas No.906673-24-3
SmilesOB1OCc2cc(Oc3ccc(cc3)C#N)ccc12
Relative Density.1.33 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (199.16 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9833 mL19.9164 mL39.8327 mL199.1635 mL
5 mM0.7967 mL3.9833 mL7.9665 mL39.8327 mL
10 mM0.3983 mL1.9916 mL3.9833 mL19.9164 mL
20 mM0.1992 mL0.9958 mL1.9916 mL9.9582 mL
50 mM0.0797 mL0.3983 mL0.7967 mL3.9833 mL
100 mM0.0398 mL0.1992 mL0.3983 mL1.9916 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Crisaborole | purchase Crisaborole | Crisaborole cost | order Crisaborole | Crisaborole chemical structure | Crisaborole in vivo | Crisaborole in vitro | Crisaborole formula | Crisaborole molecular weight